These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22917735)

  • 1. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.
    Kritzinger J; Klass D; Ho S; Lim H; Buczkowski A; Yoshida E; Liu D
    Clin Radiol; 2013 Jan; 68(1):1-15. PubMed ID: 22917735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy.
    Kouri BE
    Tech Vasc Interv Radiol; 2018 Dec; 21(4):205-222. PubMed ID: 30545499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Changes Due to Chemoembolization of Hepatocellular Carcinoma Impacting Subsequent Radioembolization.
    Patel P; Charles HW; Park J; Deipolyi AR
    J Vasc Interv Radiol; 2016 Sep; 27(9):1451-1453. PubMed ID: 27566429
    [No Abstract]   [Full Text] [Related]  

  • 4. Standards of practice in transarterial radioembolization.
    Mahnken AH; Spreafico C; Maleux G; Helmberger T; Jakobs TF
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):613-22. PubMed ID: 23511991
    [No Abstract]   [Full Text] [Related]  

  • 5. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional therapies for hepatocellular carcinoma.
    Willatt JM; Francis IR; Novelli PM; Vellody R; Pandya A; Krishnamurthy VN
    Cancer Imaging; 2012 Apr; 12(1):79-88. PubMed ID: 22487698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter intraarterial therapies: rationale and overview.
    Lewandowski RJ; Geschwind JF; Liapi E; Salem R
    Radiology; 2011 Jun; 259(3):641-57. PubMed ID: 21602502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in endovascular therapy to treat primary hepatocellular carcinoma.
    Guo Z; Yu H; Liu C; Si T; Yang X; Zhang W; Xu Y; Li Y
    Drug Discov Ther; 2015 Oct; 9(5):342-51. PubMed ID: 26632543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver chemoembolization of hepatocellular carcinoma using TANDEM
    Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C
    Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
    Rose SC; Narsinh KH; Newton IG
    J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Deploy and Retrieve" Technique Using Detachable Micro-coil for Temporary Occlusion During Drug-Eluting Beads Chemoembolization.
    Pua U
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1359-62. PubMed ID: 25672285
    [No Abstract]   [Full Text] [Related]  

  • 15. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
    Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
    Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New interventions for liver tumors.
    Ramsey DE; Geschwind JF
    Semin Roentgenol; 2002 Oct; 37(4):303-11. PubMed ID: 12455128
    [No Abstract]   [Full Text] [Related]  

  • 17. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1.
    Giunchedi P; Maestri M; Gavini E; Dionigi P; Rassu G
    Expert Opin Drug Deliv; 2013 May; 10(5):679-90. PubMed ID: 23406440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
    Brown DB; Cardella JF; Sacks D; Goldberg SN; Gervais DA; Rajan D; Vedantham S; Miller DL; Brountzos EN; Grassi CJ; Towbin RB
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):225-32. PubMed ID: 16517768
    [No Abstract]   [Full Text] [Related]  

  • 19. A rare complication after transarterial chemoembolization for hepatocellular carcinoma.
    Huang YS; Chang CC; Chang YC
    QJM; 2014 Jun; 107(6):487-8. PubMed ID: 24170892
    [No Abstract]   [Full Text] [Related]  

  • 20. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
    Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS
    J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.